078650 — G9Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩135m
- KR₩23bn
- KR₩679m
Annual cashflow statement for G9Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,275 | -8,678 | -45,532 | -37,257 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,572 | 13,418 | 22,130 | 15,162 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 880 | -6,657 | -11,544 | 6,905 | -19,740 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 17,462 | 10,865 | -20,002 | -5,783 | -17,134 |
| Capital Expenditures | -13,212 | -30,075 | -3,551 | -5,491 | -31.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2,201 | 4,176 | 6,265 | 4,643 | 19,510 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15,414 | -25,899 | 2,715 | -847 | 19,479 |
| Financing Cash Flow Items | — | -48.2 | -1,225 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -199 | 8,864 | 21,895 | 2,069 | -1,148 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,849 | -6,171 | 4,617 | -4,561 | 1,728 |